JOHN C MARTIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN C MARTIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN C MARTIN. JOHN C MARTIN is Chairman and CEO in GILEAD SCIENCES INC ($GILD).
Latest Insider Trading Transactions of JOHN C MARTIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Payment of Exercise | F | 103.84 | 244,205 | 25,358,247 | 4,255,876 | 4.5 M to 4.3 M (-5.43 %) |
Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 312,000 | 0 | 4,500,081 | 4.2 M to 4.5 M (+7.45 %) |
Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 64,846 | 0 | 4,188,081 | 4.1 M to 4.2 M (+1.57 %) |
Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 85.61 | 248 | 21,232 | 4,123,235 | 4.1 M to 4.1 M (+0.01 %) |
Feb 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 1,500,000 | |
Feb 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 106.81 | 4,067 | 434,388 | 4,122,987 | 4.1 M to 4.1 M (-0.10 %) |
Feb 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 105.99 | 44,733 | 4,741,219 | 4,127,054 | 4.2 M to 4.1 M (-1.07 %) |
Feb 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 105.14 | 101,200 | 10,639,642 | 4,171,787 | 4.3 M to 4.2 M (-2.37 %) |
Feb 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,272,987 | 4.1 M to 4.3 M (+3.64 %) |
Feb 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | A | 104.83 | 169,820 | 17,802,231 | 169,820 | |
Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 1,650,000 | |
Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 96.65 | 100 | 9,665 | 4,122,987 | 4.1 M to 4.1 M (0.00 %) |
Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 95.92 | 17,700 | 1,697,731 | 4,123,087 | 4.1 M to 4.1 M (-0.43 %) |
Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 95.01 | 132,200 | 12,559,992 | 4,140,787 | 4.3 M to 4.1 M (-3.09 %) |
Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,272,987 | 4.1 M to 4.3 M (+3.64 %) |
Dec 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,633 | 1,125,767 | 0 | |
Dec 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 101.45 | 34,900 | 3,540,661 | 4,122,987 | 4.2 M to 4.1 M (-0.84 %) |
Dec 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 100.48 | 105,733 | 10,624,168 | 4,157,887 | 4.3 M to 4.2 M (-2.48 %) |
Dec 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,633 | 1,125,767 | 4,263,620 | 4.1 M to 4.3 M (+3.41 %) |
Nov 26 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Gift | G | 0.00 | 306,400 | 0 | 4,122,987 | 4.4 M to 4.1 M (-6.92 %) |
Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 140,633 | |
Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 112.42 | 9,025 | 1,014,617 | 4,429,387 | 4.4 M to 4.4 M (-0.20 %) |
Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 111.83 | 20,400 | 2,281,405 | 4,438,412 | 4.5 M to 4.4 M (-0.46 %) |
Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 110.17 | 55,454 | 6,109,190 | 4,458,812 | 4.5 M to 4.5 M (-1.23 %) |
Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 109.78 | 55,746 | 6,119,891 | 4,514,266 | 4.6 M to 4.5 M (-1.22 %) |
Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 281,258 | |
Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 107.41 | 1,400 | 150,374 | 4,429,387 | 4.4 M to 4.4 M (-0.03 %) |
Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 106.60 | 29,725 | 3,168,795 | 4,430,787 | 4.5 M to 4.4 M (-0.67 %) |
Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 105.71 | 109,500 | 11,574,676 | 4,460,512 | 4.6 M to 4.5 M (-2.40 %) |
Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
Sep 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 421,883 | |
Sep 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 109.01 | 68,000 | 7,412,605 | 4,429,387 | 4.5 M to 4.4 M (-1.51 %) |
Sep 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 108.30 | 72,625 | 7,865,309 | 4,497,387 | 4.6 M to 4.5 M (-1.59 %) |
Sep 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
Aug 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 562,508 | |
Aug 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 92.10 | 41,500 | 3,822,017 | 4,429,387 | 4.5 M to 4.4 M (-0.93 %) |
Aug 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 91.30 | 99,125 | 9,049,795 | 4,470,887 | 4.6 M to 4.5 M (-2.17 %) |
Aug 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 703,133 | |
Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 85.40 | 18,100 | 1,545,678 | 4,429,387 | 4.4 M to 4.4 M (-0.41 %) |
Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 85.01 | 92,300 | 7,846,728 | 4,447,487 | 4.5 M to 4.4 M (-2.03 %) |
Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 83.96 | 30,225 | 2,537,555 | 4,539,787 | 4.6 M to 4.5 M (-0.66 %) |
Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 843,758 | |
Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 81.32 | 140,625 | 11,435,836 | 4,429,387 | 4.6 M to 4.4 M (-3.08 %) |
Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
May 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 984,383 | |
May 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 79.36 | 74,064 | 5,877,564 | 4,429,387 | 4.5 M to 4.4 M (-1.64 %) |
May 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 78.64 | 66,561 | 5,234,470 | 4,503,451 | 4.6 M to 4.5 M (-1.46 %) |
May 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 1,125,008 | |
Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 73.47 | 68,910 | 5,062,652 | 4,429,387 | 4.5 M to 4.4 M (-1.53 %) |
Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 73.06 | 71,715 | 5,239,376 | 4,498,297 | 4.6 M to 4.5 M (-1.57 %) |
Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Payment of Exercise | F | 79.92 | 187,848 | 15,012,812 | 4,429,387 | 4.6 M to 4.4 M (-4.07 %) |
Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 360,000 | 0 | 4,617,235 | 4.3 M to 4.6 M (+8.46 %) |
Mar 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 1,265,633 | |
Mar 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 82.36 | 40,958 | 3,373,452 | 4,257,235 | 4.3 M to 4.3 M (-0.95 %) |
Mar 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 81.49 | 99,667 | 8,121,874 | 4,298,193 | 4.4 M to 4.3 M (-2.27 %) |
Mar 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,397,860 | 4.3 M to 4.4 M (+3.30 %) |
Mar 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 21.94 | 968 | 21,243 | 4,257,235 | 4.3 M to 4.3 M (+0.02 %) |
Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 1,406,258 | |
Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 81.83 | 500 | 40,915 | 4,256,267 | 4.3 M to 4.3 M (-0.01 %) |
Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 81.17 | 32,725 | 2,656,223 | 4,256,767 | 4.3 M to 4.3 M (-0.76 %) |
Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 80.21 | 49,000 | 3,930,226 | 4,289,492 | 4.3 M to 4.3 M (-1.13 %) |
Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 79.05 | 58,400 | 4,616,724 | 4,338,492 | 4.4 M to 4.3 M (-1.33 %) |
Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,396,892 | 4.3 M to 4.4 M (+3.30 %) |
Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | A | 80.65 | 162,260 | 13,086,269 | 162,260 | |
Jan 27 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 43,146 | 0 | 4,256,267 | 4.2 M to 4.3 M (+1.02 %) |
Jan 27 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 78,000 | 0 | 4,213,121 | 4.1 M to 4.2 M (+1.89 %) |
Jan 06 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 1,546,883 | |
Jan 06 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 75.02 | 140,625 | 10,550,180 | 4,057,121 | 4.2 M to 4.1 M (-3.35 %) |
Jan 06 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,197,746 | 4.1 M to 4.2 M (+3.47 %) |
Dec 04 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 0 | |
Dec 04 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 74.79 | 17,742 | 1,326,862 | 4,057,121 | 4.1 M to 4.1 M (-0.44 %) |
Dec 04 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 74.23 | 264,500 | 19,633,835 | 4,074,863 | 4.3 M to 4.1 M (-6.10 %) |
Dec 04 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
Nov 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 282,242 | |
Nov 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 70.83 | 282,242 | 19,990,213 | 4,057,121 | 4.3 M to 4.1 M (-6.50 %) |
Nov 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
Oct 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 564,484 | |
Oct 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 62.70 | 282,242 | 17,696,545 | 4,057,121 | 4.3 M to 4.1 M (-6.50 %) |
Oct 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
Sep 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 846,726 | |
Sep 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 61.45 | 14,500 | 890,990 | 4,057,121 | 4.1 M to 4.1 M (-0.36 %) |
Sep 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 60.95 | 267,742 | 16,318,500 | 4,071,621 | 4.3 M to 4.1 M (-6.17 %) |
Sep 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
Aug 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 1,128,968 | |
Aug 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 62.04 | 36,242 | 2,248,341 | 4,057,121 | 4.1 M to 4.1 M (-0.89 %) |
Aug 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 61.55 | 246,000 | 15,141,398 | 4,093,363 | 4.3 M to 4.1 M (-5.67 %) |
Aug 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
Jul 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 1,411,210 | |
Jul 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 52.64 | 20,800 | 1,094,837 | 4,057,121 | 4.1 M to 4.1 M (-0.51 %) |
Jul 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 51.95 | 261,442 | 13,582,984 | 4,077,921 | 4.3 M to 4.1 M (-6.02 %) |
Jul 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
Jun 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 1,693,452 | |
Jun 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 54.59 | 3,542 | 193,352 | 4,057,121 | 4.1 M to 4.1 M (-0.09 %) |
Jun 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 53.99 | 24,800 | 1,339,002 | 4,060,663 | 4.1 M to 4.1 M (-0.61 %) |
Jun 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 52.80 | 225,700 | 11,916,599 | 4,085,463 | 4.3 M to 4.1 M (-5.24 %) |
Jun 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 51.91 | 28,200 | 1,463,918 | 4,311,163 | 4.3 M to 4.3 M (-0.65 %) |
Jun 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
May 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 1,975,694 | |
May 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 50.17 | 282,242 | 14,160,956 | 4,057,121 | 4.3 M to 4.1 M (-6.50 %) |
May 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
Apr 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 2,257,936 | |
Apr 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 48.47 | 181,242 | 8,784,564 | 4,057,121 | 4.2 M to 4.1 M (-4.28 %) |
Apr 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 48.01 | 101,000 | 4,848,970 | 4,238,363 | 4.3 M to 4.2 M (-2.33 %) |
Apr 03 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,339,363 | 4.1 M to 4.3 M (+6.96 %) |
Mar 08 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Payment of Exercise | F | 45.40 | 55,311 | 2,511,119 | 4,057,121 | 4.1 M to 4.1 M (-1.34 %) |
Mar 08 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 106,000 | 0 | 4,112,432 | 4 M to 4.1 M (+2.65 %) |
Mar 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 2,540,178 | |
Mar 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 43.43 | 67,535 | 2,932,755 | 4,006,432 | 4.1 M to 4 M (-1.66 %) |
Mar 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 43.05 | 214,707 | 9,243,308 | 4,073,967 | 4.3 M to 4.1 M (-5.01 %) |
Mar 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,288,674 | 4 M to 4.3 M (+7.04 %) |
Feb 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | A | 40.56 | 392,750 | 15,929,940 | 392,750 | |
Feb 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 7.63 | 282,242 | 2,154,212 | 2,822,420 | |
Feb 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 41.00 | 11,000 | 451,053 | 4,005,464 | 4 M to 4 M (-0.27 %) |
Feb 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.40 | 271,242 | 10,959,425 | 4,016,464 | 4.3 M to 4 M (-6.33 %) |
Feb 05 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 7.63 | 282,242 | 2,154,212 | 4,287,706 | 4 M to 4.3 M (+7.05 %) |
Jan 04 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 15.27 | 141,121 | 2,154,212 | 1,552,331 | |
Jan 04 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 74.67 | 52,810 | 3,943,212 | 2,002,732 | 2.1 M to 2 M (-2.57 %) |
Jan 04 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 74.34 | 88,311 | 6,565,261 | 2,055,542 | 2.1 M to 2.1 M (-4.12 %) |
Jan 04 2013 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 15.27 | 141,121 | 2,154,212 | 2,143,853 | 2 M to 2.1 M (+7.05 %) |
Dec 12 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 16.01 | 6,246 | 99,998 | 0 | |
Dec 12 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 15.27 | 6,548 | 99,955 | 0 | |
Dec 12 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 16.01 | 6,246 | 99,998 | 2,002,732 | 2 M to 2 M (+0.31 %) |
Dec 12 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 15.27 | 6,548 | 99,955 | 1,996,486 | 2 M to 2 M (+0.33 %) |
Dec 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 134,320 | 1,201,157 | 0 | |
Dec 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 11,180 | 99,977 | 0 | |
Dec 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 75.33 | 67,242 | 5,065,246 | 1,989,938 | 2.1 M to 2 M (-3.27 %) |
Dec 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 74.74 | 78,258 | 5,849,347 | 2,057,180 | 2.1 M to 2.1 M (-3.66 %) |
Dec 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 11,180 | 99,977 | 2,135,438 | 2.1 M to 2.1 M (+0.53 %) |
Dec 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 134,320 | 1,201,157 | 2,124,258 | 2 M to 2.1 M (+6.75 %) |
Nov 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 134,320 | |
Nov 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 68.18 | 15,100 | 1,029,569 | 1,989,938 | 2 M to 2 M (-0.75 %) |
Nov 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 67.65 | 130,350 | 8,818,021 | 2,005,038 | 2.1 M to 2 M (-6.10 %) |
Nov 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,135,388 | 2 M to 2.1 M (+7.31 %) |
Oct 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 279,770 | |
Oct 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 68.09 | 14,000 | 953,240 | 1,989,938 | 2 M to 2 M (-0.70 %) |
Oct 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 67.47 | 131,450 | 8,869,392 | 2,003,938 | 2.1 M to 2 M (-6.16 %) |
Oct 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,135,388 | 2 M to 2.1 M (+7.31 %) |
Sep 06 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 425,220 | |
Sep 06 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 58.13 | 32,304 | 1,877,861 | 1,989,938 | 2 M to 2 M (-1.60 %) |
Sep 06 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 57.56 | 113,146 | 6,512,152 | 2,022,242 | 2.1 M to 2 M (-5.30 %) |
Sep 06 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,135,388 | 2 M to 2.1 M (+7.31 %) |
Aug 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 570,670 | |
Aug 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 54.25 | 56,313 | 3,054,963 | 1,989,938 | 2 M to 2 M (-2.75 %) |
Aug 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 53.84 | 89,137 | 4,799,127 | 2,046,251 | 2.1 M to 2 M (-4.17 %) |
Aug 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,135,388 | 2 M to 2.1 M (+7.31 %) |